Mauritius vs Turkmenistan: Previously treated cases tested for RR-/MDR-TB
Mauritius
100.0%
in 2022
Turkmenistan
100.0%
in 2022
Mauritius rank
1st
Turkmenistan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Mauritius
- Turkmenistan
How they compare
Mauritius currently reports 100.0% against 100.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2006 it was Mauritius ahead.
Mauritius ranks 1st and Turkmenistan ranks 1st of 180 countries.
Mauritius has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritius | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 42.0% | 58.0% | Mauritius |
| 2010s | 100.0% | 55.0% | 45.0% | Mauritius |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mauritius or Turkmenistan?
- Mauritius, at 100.0% against 100.0% in Turkmenistan as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mauritius and Turkmenistan?
- 0.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Turkmenistan?
- 6 years are reported by both, from 2006 to 2022.
- How do Mauritius and Turkmenistan rank globally for previously treated cases tested for rr-/mdr-tb?
- Mauritius ranks 1st and Turkmenistan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.